Hong Kong · Delayed Price · Currency is HKD Suzhou Ribo Life Science Statistics
Total Valuation
HKG:6938 has a market cap or net worth of HKD 9.84 billion. The enterprise value is 7.97 billion.
| Market Cap | 9.84B |
| Enterprise Value | 7.97B |
Important Dates
The last earnings date was Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:6938 has 170.55 million shares outstanding. The number of shares has increased by 16.57% in one year.
| Current Share Class | 170.55M |
| Shares Outstanding | 170.55M |
| Shares Change (YoY) | +16.57% |
| Shares Change (QoQ) | +26.11% |
| Owned by Insiders (%) | 13.73% |
| Owned by Institutions (%) | 2.67% |
| Float | 101.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.35 |
| PB Ratio | 4.63 |
| P/TBV Ratio | 5.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.28, with a Debt / Equity ratio of 0.29.
| Current Ratio | 5.28 |
| Quick Ratio | 4.91 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.18 |
Financial Efficiency
Return on equity (ROE) is -17.59% and return on invested capital (ROIC) is -4.99%.
| Return on Equity (ROE) | -17.59% |
| Return on Assets (ROA) | -3.85% |
| Return on Invested Capital (ROIC) | -4.99% |
| Return on Capital Employed (ROCE) | -5.01% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.18M |
| Profits Per Employee | -432,328 |
| Employee Count | 453 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 0.65 |
Taxes
In the past 12 months, HKG:6938 has paid 63.62 million in taxes.
| Income Tax | 63.62M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 53.69 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 50.58 |
| Average Volume (20 Days) | 445,000 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:6938 had revenue of HKD 536.18 million and -195.84 million in losses. Loss per share was -1.30.
| Revenue | 536.18M |
| Gross Profit | 494.14M |
| Operating Income | -135.67M |
| Pretax Income | -129.46M |
| Net Income | -195.84M |
| EBITDA | -92.54M |
| EBIT | -135.67M |
| Loss Per Share | -1.30 |
Balance Sheet
The company has 2.63 billion in cash and 626.60 million in debt, with a net cash position of 2.00 billion or 11.72 per share.
| Cash & Cash Equivalents | 2.63B |
| Total Debt | 626.60M |
| Net Cash | 2.00B |
| Net Cash Per Share | 11.72 |
| Equity (Book Value) | 2.13B |
| Book Value Per Share | 11.71 |
| Working Capital | 2.35B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 43.67M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 92.16%, with operating and profit margins of -25.30% and -36.53%.
| Gross Margin | 92.16% |
| Operating Margin | -25.30% |
| Pretax Margin | -24.14% |
| Profit Margin | -36.53% |
| EBITDA Margin | -17.26% |
| EBIT Margin | -25.30% |
| FCF Margin | n/a |
Dividends & Yields
HKG:6938 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.57% |
| Shareholder Yield | -16.57% |
| Earnings Yield | -1.99% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for HKG:6938 is 100.07, which is 74.34% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 100.07 |
| Price Target Difference | 74.34% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 13.18% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |